Healthcare provider profile · identity verified

Michael Lawrence, MD

Family Practice · SNOW HILL, NC · NPI 1518933415

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	521	72
Amlodipine Besylate	Amlodipine Besylate	419	61
Trazodone Hcl	Trazodone Hcl	344	53
Memantine Hcl	Memantine Hcl	292	35
Levothyroxine Sodium	Levothyroxine Sodium	268	30
Lisinopril	Lisinopril	257	34
Eliquis	Apixaban	245	36
Potassium Chloride	Potassium Chloride	236	38
Gabapentin	Gabapentin	210	36
Pantoprazole Sodium	Pantoprazole Sodium	208	36
Losartan Potassium	Losartan Potassium	204	28
Sertraline Hcl	Sertraline Hcl	203	29
Mirtazapine	Mirtazapine	193	37
Furosemide	Furosemide	180	28
Donepezil Hcl	Donepezil Hcl	173	22
Rosuvastatin Calcium	Rosuvastatin Calcium	171	25
Jardiance	Empagliflozin	145	17
Escitalopram Oxalate	Escitalopram Oxalate	143	24
Omeprazole	Omeprazole	142	29
Tamsulosin Hcl	Tamsulosin Hcl	140	22
Metoprolol Succinate	Metoprolol Succinate	139	27
Januvia	Sitagliptin Phosphate	134	13
Metoprolol Tartrate	Metoprolol Tartrate	132	23
Clopidogrel	Clopidogrel Bisulfate	118	15
Tramadol Hcl	Tramadol Hcl	117	20
Carvedilol	Carvedilol	116	19
Metformin Hcl	Metformin Hcl	114	18
Allopurinol	Allopurinol	108	16
Incruse Ellipta	Umeclidinium Bromide	98	suppressed
Pravastatin Sodium	Pravastatin Sodium	88	13
Labetalol Hcl	Labetalol Hcl	84	suppressed
Divalproex Sodium	Divalproex Sodium	83	13
Hydralazine Hcl	Hydralazine Hcl	78	12
Lamotrigine	Lamotrigine	76	suppressed
Alendronate Sodium	Alendronate Sodium	74	11
Aripiprazole	Aripiprazole	72	suppressed
Spironolactone	Spironolactone	72	12
Clonidine Hcl	Clonidine Hcl	67	12
Levetiracetam	Levetiracetam	67	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	66	15
Quetiapine Fumarate	Quetiapine Fumarate	63	15
Duloxetine Hcl	Duloxetine Hcl	61	11
Silver Sulfadiazine	Silver Sulfadiazine	61	14
Famotidine	Famotidine	59	suppressed
Finasteride	Finasteride	56	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	53	suppressed
Simvastatin	Simvastatin	53	suppressed
Trulicity	Dulaglutide	53	suppressed
Torsemide	Torsemide	50	suppressed
Alprazolam	Alprazolam	49	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	49	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	35
Prednisone	Prednisone	47	18
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Rexulti	Brexpiprazole	45	suppressed
Divalproex Sodium Er	Divalproex Sodium	42	suppressed
Lactulose	Lactulose	42	suppressed
Tradjenta	Linagliptin	42	suppressed
Benztropine Mesylate	Benztropine Mesylate	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Metformin Hcl Er	Metformin Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Insulin Lispro	Insulin Lispro	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Lacosamide	Lacosamide	37	suppressed
Baclofen	Baclofen	35	suppressed
Fentanyl	Fentanyl	34	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Ketoconazole	Ketoconazole	31	15
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	17
Montelukast Sodium	Montelukast Sodium	27	suppressed
Risperidone	Risperidone	26	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	15
Megestrol Acetate	Megestrol Acetate	25	suppressed
Ozempic	Semaglutide	25	suppressed
Fluconazole	Fluconazole	24	14
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Levofloxacin	Levofloxacin	24	16
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	24	suppressed
Zaleplon	Zaleplon	23	suppressed
Topiramate	Topiramate	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Clonidine	Clonidine	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Humalog	Insulin Lispro	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Linzess	Linaclotide	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Vilazodone Hcl	Vilazodone Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	12
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	11
Primidone	Primidone	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Lurasidone Hcl	Lurasidone Hcl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Cyclosporine	Cyclosporine	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	14	suppressed
Tiotropium Bromide	Tiotropium Bromide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Corlanor	Ivabradine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Digoxin	Digoxin	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Methimazole	Methimazole	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Austedo	Deutetrabenazine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Levetiracetam Er	Levetiracetam	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error